Friday, November 22, 2013

Transparency Market Research is Published new Market Report“Prefilled Syringes Market (Glass and Plastic) - Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast, 2013 - 2019,"The global prefilled syringes market was valued at USD 2.09billion in 2012 and is expected to grow at a CAGR of 13.3% from 2013 to 2019, to reach an estimated value of USD 4.98billion in 2019.

Prefilled syringes are advanced drug delivery devices filled with single measured dose of high-end injectable drugs. Thesesyringes are gradually becoming the most preferred delivery devices for various categories of injectable drugs, mainly due to the advantages offered to drug manufacturers, healthcare providers and patients over conventional vial and ampoule packaging systems. To drug manufacturers, they are important because they reduce overfill to 4%-5% from 20% in vials, and thus, are preferred for dispensing therapeutic classes (mainly biologics) which are expensive. With respect to healthcare providers and patients, prefilled syringes help with factors such as ease of operation, low risk of contamination and accurate dosing.

Glass has been the most preferred material over decades for syringe manufacturing, owing to its properties such as non-reactive nature, robustness, transparency and tolerability against heat. Consequently, glass based prefilled syringes accounted for the larger share(more than 90%) of the total market in 2012, both by revenue as well as volume.Sincethe past few years, the industry is witnessing a shift towards the usage of plastic in place of glass in response to some significant disadvantages associated with glass, such as high risk of breakability and increased level of leachability from silicone layer in the presence of biologics. Under the influence of continued development in the area of polymer technology, the market for plastic based syringes is expected to grow at a CAGR more than double of that of glass syringes duringthe forecast period from 2013 to 2019. Nevertheless, glass syringes will still dominate the total global market for prefilled syringes in 2019, in terms of percent share by revenue as well as volume.

Boost in the use of biologics and other potent injectable drugs, technical advances in prefilled syringe manufacturing and packaging, rising demand for self-administration and increasing elderly population suffering from various chronic diseases that require frequent parenteral dosing are some major drivers anticipated totrigger market growth during the forecast period. On the other hand, burgeoning concerns regarding needlestick safety and prevention, rising manufacturing costs and issues with drug stability are some of the challenges likely to affect the growth of the global prefilled syringes market.

Geographically, Europe constituted the largest market share for prefilled syringes in 2012, owing to the high adoption rate of these delivery devices in the region. However, the North American market is predicted to grow at a higher CAGR (15%) than Europe during the forecast period to reach a value similar to that of the European market. Major drivers expected to contribute to this market growth include increasing awareness regarding benefits of prefilled syringes and presence of a large number of biopharmaceuticals under clinical development targeted for parenteral administration. In addition, the high growth economies of emerging nations such as India, China, Brazil, Russia and Mexico are attracting manufacturers to invest in these lucrative markets. Japan is a well-established market for prefilled syringes among Asian countries.

The market for prefilled syringes is oligopolistic in nature and is dominated by a few key players, namely, Becton, Dickinson and Company, Gerresheimer AG, Nipro Corporation, Schott AG and Stevanato Group. Other vendors operating in the market include Unilife Corporation, West Pharmaceutical Services, Inc., Baxter International, Inc. and Ypsomed Holding AG.

Friday, October 25, 2013

Transparency Market Research is Published
new Market Report “Aquaculture (Marine Water, Freshwater and Brackish Water)
Market for Carp, Molluscs, Crustaceans, Salmon, Trout and Other Fishes - Global
Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the
global market for aquaculture was valued at USD 135.10 billion in 2012 and is
expected to reach USD 195.13 billion in 2019, growing at a CAGR of 5.1% from
2013 to 2019. In terms of volume, global production was 66.5 million tons in
2012 and is expected to grow at a CAGR of 2.3% from 2013 to 2019.

Volume of captured fish is fast depleting and is expected to be one of
the primary factors driving global aquaculture production over the next few
years. In addition, increasing consumer awareness regarding health benefits associated
with consumption of fish and fish products is expected to boost aquaculture
production within the forecast period. Aquaculture is expected to surpass
captured fish industry as the major source for human consumption by the end of
2015. However, parameters such as adverse environmental conditions and lack of
technology are expected to hamper the growth of the market. Increasing practice
of rice and fish farming, which aims at increasing yields of rice grains as
well as fishes is expected to open new opportunities for the growth of the
market within the near future.

Aquaculture practiced in fresh water was the largest culture environment
segment in 2012 accounting for over 60% of the production. It is expected to be
one of the fastest growing segments over the next few years on account of
simulation of the culture environment in enclosed areas such as ponds, cages
and concrete raceways. Aquaculture practiced in marine water is expected to
grow at a CAGR 2.4% from 2013 to 2019 on account of increased consumer
demand for sea water fishes.

Carps were the biggest product segment within the market and accounted
for over 35% of the global production in 2012. Carps, particularly common
carps, have been one of the majorly farmed aquatic species in the industry
owing to their compatibility in less than ideal environmental conditions.
Mollusks such as clams and mussels have been an important food source and are
expected to witness the fastest growth over the next few years. This segment is
expected to grow at a CAGR of 2.6% from 2013 to 2019, owing to their
increasingly use in poly culture systems such as rice and fish farming.

China dominated aquaculture production and accounted for over 60% of the
total share in 2012. In addition, this region is expected to witness the
fastest growth within the forecast period. Cheap labor, ease of availability of
natural resources and induced conditions for aquaculture are some of the key
factors which are expected to contribute significantly to the growth of the
market in this region over the next few years.

The report gives a comprehensive view of the aquaculture market in terms
of volume and revenue. In addition, the report includes current production
analysis and forecast for each culture environment and product segment in North
America, Europe, Asia Pacific (excluding China), China and Rest of
the World (RoW). The report comprises of the following segments:

Aquaculture Market:
Culture Environment Segment Analysis

Freshwater

Marine water

Brackish water

Aquaculture
Market: Product Segment Analysis

Carps

Mollusks

Crustaceans

Salmon

Milkfish

Trout

Mackerel

Sea Bream

Sea Bass

Others (Catfish and
turbot)

The
report provides a cross-sectional analysis of all the above product segments
with respect to the following regions:

Medical tourism is defined as an act of travel of patients from their home country to other destinations for availing medical services. Rise in healthcare costs in developed countries coupled with the availability of high quality medical services at a low cost in developing countries have given a boost to the medical tourism industry. These medical services range from elective procedures such as cosmetic surgeries to complicated surgeries such as cardiac, orthopedics, neurosurgery and others. Significant growth in this industry is due to economic developments in developing countries that in turn has led to the growth in the medical industry and quality of medical services.

Rise in the healthcare expenditure in developed countries coupled with in the growing elderly population has also contributed to the gowth of the medical tourism across the globe. Economic crisis in the U.S., increased the number of uninsured population, consequently further triggering the growth of this market. Recently, there are approximately 50 million uninsured Americans that are willing to travel abroad for affordable and quality medical care. Globalization and improved communication technology act as a catalyst to boost the growth of this industry.

The development of medical tourism industry is based on several factors such as reduced cost of procedures, long waiting time and high demand for cosmetic surgeries. Medical travel is not only witnessed for intricate procedures but is also expanding due to growing demand for cosmetic and dental procedures since these are usually not reimbursed under regular health insurance policies. Patients travelling abroad can save from 30% to 90% on a procedure, including their travel expenditures, as compared to the medical costs in their own countries. Long waiting time is another factor which has substantially boosted the growth of this industry. Patients based in Canada and U.K travel to low cost destinations for their treatments in order to avoid long waiting periods in their own countries and receive timely access to serious ailments.

Medical tourism industry is dominated by the Asian region that has captured the maximum share of the market. This region is highly competitive owing to the presence of technologically advanced medical specialties, less stringent government regulations and attractive locations. Thailand and India are recognized internationally for their high end medical services and receive patients from across the globe. Singapore is renowned for its healthcare infrastructure and receives patients primarily for complex medical procedures. Thailand, India and Singapore accounted for approximately 60% of the total revenue of the Asian region in 2012. The Latin American countries such as Brazil and Mexico attract maximum number of patients from the U.S owing to the geographic proximity and cultural similarities. Similarly, growth in Turkey is witnessed on account of growing demand of cosmetic surgeries.

However, a paradigm shift in the market is seen owing to strong competition among the players of this industry. Malaysia is poised to have a significant growth in this market and is likely to emerge as a fastest growing country in terms of medical tourism with a CAGR of over 25% from 2013 to 2019. This advent in Malaysian medical tourism market is due to cost advantage over Thailand and Singapore. Moreover, rise in popularity of Malaysian region is attributed to many factors such as advanced healthcare infrastructure, highly skilled professionals, visa benefits and others. Additionally, robust government support for promotion of Malaysian medical tourism has propelled the growth in this nation.

Moreover, increase in the government initiatives and growing inclination of private sector hospitals towards medical tourism is further supplanting the growth of this market. Key healthcare providers in this industry include Apollo Hospitals Enterprise Ltd., Bumrumgrad International Hospital, Bangkok Medical Center, Prince Court Medical Center and others.

The Medical Tourism market is segmented as follows:

The global medical tourism market is segmented into the following categories:

Rising global base of geriatric population inducing an accelerated growth in the incidence rates of atrial fibrillation is one of the highest impact-rendering drivers for this market. In addition, favorable results exhibited by clinical trials promoting combined pharmacological therapy such as the HARMONY trial and rising prevalence of disorders causing atrial fibrillation such as hypertension and obesity will also serve the market as drivers. The future growth of this market will be ensured by the introduction of advanced treatment procedures such as hybrid ablation and the rising prevalence of atrial fibrillation in emerging Asian economies.

On account of the fact that pharmacological treatment procedures are more frequently administered to the patients suffering from atrial fibrillation and are a cheaper alternative to non-pharmacological procedures, pharmacological procedures held the majority of market share in 2012. With the introduction of new drugs such as Bristol Myer Squibb's NTC-801, Merck's Vernakalant, Boehringer Ingelheim's Pradaxa, the market share of pharmacological treatment procedures is expected to further increase by 2019.

The non-pharmacological treatment market was led by the catheter ablation market and its market share was valued at over 45% in 2012. The introduction of new catheter ablation systems such as CardioFocus's HeartLight Endoscopic Ablation System (EAS) laser ablation catheter, Endosense's TactiCath and Biosense Webster's ThermoCool SmartTouch, will help the catheter ablation market to further enhance its market share by 2019.

The radiofrequency based catheter ablation treatment for atrial fibrillation market led the catheter ablation market in terms of market share in 2012 majorly on account of the facts that it has a relatively lower procedural duration and cost and has high success rates associated with it.

High prevalence of atrial fibrillation coupled with the availability of high disposable incomes amongst patients and sophisticated healthcare infrastructure, has led the North American atrial fibrillation market to hold the majority of the market share in 2012. However, this region is expected to lose its market share to relatively faster growing Asia-Pacific region.

Some of the key players of this market include Boehringer Ingelheim, Bristol-Myers Squibb/Pfizer, Bayer/Johnson & Johnson, Medtronic, Inc., St. Jude Medical, Inc. and AtriCure, Inc.

The global atrial fibrillation market is categorized into the following segments:

Wednesday, October 9, 2013

Transparency Market Research is Published
new Market Report "Home
Automation Market – Global Industry Analysis, Size, Share, Growth, Trends, and
Forecast, 2013 – 2019,” the market was valued at USD 3.6 billion in 2012 and
is expected to reach USD 16.4 billion by 2019, growing at a CAGR of 24.6% from
2013 to 2019.

Underpinning demand for a universal solution, which is easy to install
and integrate with different sub-systems in a home has induced a disruptive
growth phase in the industry. Broadband service providers, telcos, utilities
and others, who are entering the market with packaged/bundled services, have
further intensified competition in the market. This has made end-consumers as
final beneficiaries, who are able to reap benefits of price competitiveness.
However, with entry of large number of players across all levels of supply
chain, the market has been witnessing a piling of too many solutions available
to end consumers. Subsequently, proprietary platform based systems have
outnumbered the open-platform systems which has made things complex for end-users.

Standing at the point of inflection, home automation market is estimated
to see North America retain its position as the largest market. Revival of
construction activities, especially on new residential buildings and
renovations, is expected to support market growth in the region. Of all the
applications of home automation systems, growing consumer preference for safety
and security solutions is expected to result in ‘safety and security segment’
dominate market growth across all these regions. Energy management and HVAC
automation systems too are expected to see a similar growth phase towards
second half of the forecast period. Deployment of smart meters and need to curb
household energy bills is further expected to drive the demand for such
systems, especially in Europe and North America, which are at the forefront of
smart meter installation.

Among networking platforms available, wireless systems are estimated to
account for more than half the market share. Their revenue contribution is
further expected to increase with the growth of alliances such as Zigbee,
Z-Wave, and KNX. However, with the potential entry of Wi-Fi Direct and its
possible adoption by Apple may disrupt expected market gains by other wireless
technologies in the market. This is even expected to bring DIY type of
automation solutions to the forefront of the home automation market, which till
now was dominated by luxury systems, with mainstream systems and managed
automation services showing promising growth signs. Amidst growing popularity
of wireless technologies, power-line and fixed-wire home automation systems are
forecast to see decline in market share.

Some of the key market players include Crestron Electronics, Inc., ADT
Corporation, AMX LLC, and Control4 Corporation; accounting for more than 35% of
the market share. A large part of the market is catered by players specializing
in specific applications and those with generalized solutions. Other key
participants include Lutron Electronics Company, Inc., ABB Ltd., Nortek, Inc.,
Vantage Controls, Schneider Electric SA, SoftAtHome, LivingTech, among others.